
Ask a doctor about a prescription for Catalin
Pirenoxine
Catalin is indicated for the treatment of age-related cataracts. The active substance of Catalin is pirenoxine. The packaging contains a tablet and a solvent; the tablet is light orange and the solvent is clear and colorless. Although the cause of cataract formation has not been fully explained, it is believed that lens clouding occurs due to the conversion of its soluble proteins into insoluble proteins. Catalin inhibits and prevents the progression of cataracts.
If the patient is allergic to pirenoxine or any of the other ingredients of this medicine (listed in section 6).
Before starting to use Catalin, the patient should discuss it with their doctor or pharmacist.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. There is no data on interactions with other medicines or other types of interactions.
Not applicable.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine. There is no data on the safety of using Catalin during pregnancy and breastfeeding.
Catalin does not affect the ability to drive or use machines.
which may cause allergic reactions (possible late reactions).
This medicine should always be used according to the doctor's or pharmacist's recommendations. In case of doubts, the patient should consult their doctor or pharmacist.
Method of preparing the solution
Dissolve the tablet in 15 ml of solvent. A clear, yellow solution is formed.
Available packaging1 tablet and 15 ml of solvent.

Remove the white
cap from the
bottle.
Open the
tablet packaging and
put it into the
bottle. Do not
touch the tablet
directly.
Before use,
remove the brown
stopper.
Instill into the eye.
Do not touch the eye
with the dropper tip.
Close the bottle
tightly and
shake until the
tablet is dissolved.
Method of administration:
Dosage
Instill 1 or 2 drops into the conjunctival sac 3 to 5 times a day.
There are no known symptoms of overdose of Catalin in humans. An antidote is not necessary, as overdosing on pirenoxine is practically impossible.
Like all medicines, Catalin can cause side effects, although not everybody gets them.
If the patient experiences any allergic reactions, including rash, swelling of the face, lips, tongue, and/or throat, which may cause difficulty breathing or swallowing, or other serious side effects, they should stop using Catalin and contact their doctor or the Emergency Department of the nearest hospital immediately.
During treatment with Catalin, the following may occur:
Rarely (less than 1 in 1000 people):
diffuse superficial keratitis, blepharitis, conjunctival hyperemia, pain, itching.
Reporting side effects
If any side effects occur, including any side effects not listed in this leaflet, the patient should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C,
02-222 Warsaw,
tel.: +48 22 49 21 301
fax: +48 22 49 21 309
e-mail: [email protected]
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and label.
Store in a temperature below 25°C. After preparing the solution, store it in a cool place, protected from light. Shelf life after dissolving the tablet: 20 days.
The active substance of Catalin is pirenoxine in the form of sodium salt, in a dose of 0.75 mg.
The other ingredients are:
The carton contains a tablet placed in a blister pack made of Al/PCV film and a solvent placed in a 15 ml PP bottle. The tablet is light orange, and the solvent is clear and colorless.
Senju Poland Sp. z o.o.
Rondo Ignacego Daszyńskiego 2B,
00-843 Warsaw
tel.: +48 22 236 05 05
e-mail: [email protected]
PROFARM PS Sp. z o.o.
ul. Słoneczna 96
05-500 Stara Iwiczna
FARMACOL S.A.
ul. Szopienicka 77
40-431 Katowice
Synoptis Industrial Sp. z o.o.
ul. Rabowicka 15
62-020 Swarzędz
To obtain more detailed information, please contact the marketing authorization holder.
Date of last update of the leaflet:07/2024
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Catalin – subject to medical assessment and local rules.